Colorectal Cancer Screening: How Technology Can Increase Screening Rates
Josh Sclar, MD, MPH
Chief Medical Officer, BioIQ
It’s 2018, which means the moment of truth has arrived for the National Colorectal Cancer Roundtable’s “80% by 2018” initiative for colorectal cancer screening. Needless to say, we’re not measuring up. And with the American Cancer Society lowering their recommendation of age that screening should start — from 50 to 45 — even more unscreened people may need this critical test. We discuss how technology, convenience and personalization can transform colorectal cancer screening rates and save more lives.
Joshua Sclar, MD, MPH, is BioIQ’s Chief Medical Officer. Sclar is board certified in preventive medicine and public health and has over 15 years experience in healthcare. His career has spanned clinical practice, health services research and public health instruction in addition to building innovative, prevention-oriented healthcare delivery models for academia and business.
Prior to joining BioIQ, Sclar was the Chief Medical Officer at Ingenios Health Co., which developed one of the first purpose-built mobile technology platforms for health risk assessment. Sclar was a member of the steering committee that created the Johns Hopkins Sibley Innovation Hub and served as its first Lead Designer and Innovator in Residence. He has published research on a variety of topics in healthcare delivery while working at the FDA, Columbia University Medical Center, and the Johns Hopkins Center for Public Health and Human Rights. He has also been a full-time practicing physician at St. Luke’s Hospital in St. Louis, MO.
Sclar received his medical degree from the State University of New York and completed residency training at Johns Hopkins. He earned a master’s degree in public health as a BJC Healthcare Scholar at Washington University in St. Louis, and holds a bachelor’s degree from the University of Miami.
View This Webinar